With the country’s first ever drug testing control laboratory yet to be officially inaugurated, the market continues to be flooded with substandard and adulterated drugs which pose a serious threat to public health.
Following directives from the health ministry, recent drives by the Rapid Action Battalion and mobile courts of the drug administration recovered large amounts of unauthorised fake drugs, including saline and life-saving antibiotics, from different areas in the capital.
Earlier, the parliamentary standing committee on health ministry identified 62 drug companies as “substandard” and later revised the number to 29 companies and recommended banning their production.
Currently the country has more than 250 pharmaceuticals companies that manufacture around 24,000 brand drugs.
Several pharmaceutical industry specialists told the Dhaka Tribune that the remarkable success made by the country’s pharmaceutical companies was being damaged because of a handful of unscrupulous traders who manufactured and supplied fake, unregistered, substandard, adulterated and smuggled drugs. Random drug samples should be collected from the market and then tested at the National Control Laboratory to ensure drug quality, they added.
Muktadir Chowdhury, secretary general of Bangladesh Association of Pharmaceuticals Industry, recently said Bangladesh had a bright future in the drug sector, but the country needed to ensure that not a single fake or adulterated drug made it to the market.
Although the Directorate General of Drug Administration (DGDA) began testing vaccines and drugs at the control lab on January 1 this year, the Tk25 crore drug testing facility was yet to be officially inaugurated. The lab was currently testing only 300-500 samples a month, although it had the capacity to test 10,000 drug samples a year.
Several officials of the DGDA, seeking anonymity, claimed that the National Control Laboratory did not have its own budget to administer the laboratory activities, while the day-to-day expenses were being provided by the Institute of Public Health (IPH).
Although the laboratory was fully-equipped with modern machines and other testing facilities, there was also a shortage of well-trained manpower, they added.
The health ministry had created 236 new posts for the control lab, but the ministries of establishment and finance were yet to give the final approval for recruiting the manpower.
However, the Dhaka Tribune has learned that in the absence of any individual budget allocation for the control lab, the DGDA authority was conducting its tests by receiving financial and other assistance, such as chemicals, reagents and manpower, from different private pharmaceutical companies.
Selim Barami, director (current charge) of the control lab and also a director of the DGDA, admitted that it was “partially true” that the lab received help from different pharmaceutical companies for running a few tests, especially for testing vaccines.
It was not possible to conduct the tests with the limited financial allocation from the IPH, as the price of vaccine’s chemicals and reagents were very expensive, he added.
Separate monthly allocation of at least Tk1 lakh was needed to run the control lab properly, Barami said, adding that the vacant posts of 236 employees should be recruited soon.
The DGDA director further claimed that drug test results at the control lab were similar to the standards of top pharmaceutical companies.